SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-323744
Filing Date
2021-11-09
Accepted
2021-11-09 07:13:03
Documents
14
Period of Report
2021-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d256728d8k.htm   iXBRL 8-K 25033
2 EX-99.1 d256728dex991.htm EX-99.1 59587
6 GRAPHIC g256728g1106021749015.jpg GRAPHIC 3629
  Complete submission text file 0001193125-21-323744.txt   224693

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tngx-20211109.xsd EX-101.SCH 2888
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE tngx-20211109_lab.xml EX-101.LAB 18887
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tngx-20211109_pre.xml EX-101.PRE 11857
7 EXTRACTED XBRL INSTANCE DOCUMENT d256728d8k_htm.xml XML 3469
Mailing Address 100 BINNEY ST SUITE 700 CAMBRIDGE MA 02142
Business Address 100 BINNEY ST SUITE 700 CAMBRIDGE MA 02142 (857) 320-4900
Tango Therapeutics, Inc. (Filer) CIK: 0001819133 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39485 | Film No.: 211389847
SIC: 2834 Pharmaceutical Preparations